4CMenB has the potential to reduce serogroup B meningococcal disease substantially. Despite its potential, the vaccine may have some limitations, and it remains to be seen if booster doses will be required to sustain protection.
Despite a reduction in pertussis among younger children and infants, rates of pertussis-related sickness and death remain high compared with rates for other vaccine-preventable diseases in England and Wales.
Starting 15 September 2011, ECDC will be coordinating the former EUVAC.NET network. It is a surveillance network covering measles, mumps, rubella, congenital rubella, pertussis and varicella EU Member States and three countries of the European Economic Area. Data will be hosted by the European Surveillance System (TESSy) at ECDC.
The emergence of cholera in Haiti once again reminds us of the ferocity with which infectious diseases can strike and of the complex interactions of emerging infectious diseases with social conditions, human migration, and the ecosystem.
Location:Hilton Am Stadtpark, Vienna, Austria
Organized by:International Society for Infectious Diseases (ISID)